For Our Patients


Clinical Trials and Research

Thank you for your interest in enrolling in one of our studies.

New patients interested in participating in a clinical trial and in enrolling to possibly receive the newest, most advanced treatment for their vitreoretinal conditions, with the care and attention from our professional clinical trial staff.

Currently Enrolling Studies

New patients interested in enrolling a study, please click on the Enroll in this Study to send us an email. Include your name, the reason of your interest in this study and the office location you receive treatment. You will receive a reply from us within 48 - 72 hours.

The following studies are currently available for enrollment.

For Central Florida Patients

Genentech for Diabetic Macular Edema in underrepresented patients

A PHASE IIIB/IV, Multicenter, Open-label, Single-arm study to investigate Faricimab (RO6867461) Treatment response in treatment-naïve, Underpresented patients with Diabetic Macular Edema.


Kodiak KS301P106 (Glow) for Nonproliferative Diabetic Retinopathy

A Prospective, Randomized, Double-masked, Sham-controlled, Multicenter, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants with Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR)


Oculis DX219 Diabetic Macular Edema

A Phase 2/3 Pivotal, Double-Masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema


Notal Vision, Inc WET MACULAR DEGENERATION

The Evaluation of the Agreement and Precision of the Notal Vision Home OCT in the Automatic Fluid Quantification in Patients with NV-AMD


New Day is for Diabetic Macular Edema

A Randomized, Masked, Controlled Study of and Intravitreal ILUVIEN implant as baseline therapy in patients with Early Diabetic Macular Edema Gyroscope for Geographic Atrophy Secondary to Age Related Macular Degeneration To evaluate subjects with for Geographic Atrophy Secondary to Age Related Macular Degeneration by sequencing selected genes associated with AMD. Subjects who meet eligibility criteria will have the option to participate in ongoing or future Gyroscope Therapeutic sponsored studies


Gyroscope for Geographic Atrophy Secondary to Age Related Macular Degeneration

To evaluate subjects with for Geographic Atrophy Secondary to Age Related Macular Degeneration by sequencing selected genes associated with AMD. Subjects who meet eligibility criteria will have the option to participate in ongoing or future Gyroscope Therapeutic sponsored studies


Enroll in a Study

Closed for Enrollment

Hornbill is for Diabetic Retinopathy with Diabetic Macula Ischemia

A study to test the different doses of BI 764524 in patients who have had laser treatment for a type of diabetic eye disease called Diabetic Retinopathy with Diabetic Macula Ischemia

Condor is for Proliferative Diabetic Retinopathy

A 96-week, two-arm, randomized, single-masked, multicenter, phase III study assessing the efficacy and safety of brolucizumab 6mg compared to panretinal photocoagulation laser in patients with proliferative diabetic retinopathy

Photon Diabetic Macular Edema

A radomized, double-masked, active-controlled phase 2/3 study of the efficacy and safety of high-dose aflibercept in patients with diabetic macular edema

Pulsar WET Macular Degeneration

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Kodiak Beacon KS301P103 Macualar Edema secondary to Retinal Vein Occlusion

A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared with Intravitreal Aflibercept in Participants with Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)

Kodiak P104 (Gleam) for Diabetic Macular Edema

Randomized, Double masked Phase 3 study to evaluate the efficacy and safety of intravitreal KSI-301 compared with intravitreal Aflibercept in participants with visual impairment secondary to TREATMENT-NAÏVE Diabetic Macular Edema.

Kodiak Ks301P107 (Daylight) is for Wet Macular Degeneration

A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared with Intravitreal Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)


For North Florida Patients

F. Hoffmann-La Roche- Diabetic Macular Edema

A Phase II, Multicenter, Randomized, Double Masked, Active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with Diabetic Macular Edema.


OcuTerra Therapeutics, Inc- Diabetic Retinopathy (DR)

A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)


DRCR-Protocol AF- Non-Proliferative Diabetic Retinopathy

A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening.


Adverum Biotechnologies, Inc- Neovascular ( Wet) Age-Related Macular Degeneration

A Multi-Center, Randomized, Double-Masked Phase 2 Study to Assess Safety and Efficacy of ADVM-022 in Anti-VEGF Treatment-Experienced Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD) (LUNA)


Gyroscope-Geographic Atrophy Secondary to Age-Related Macular Degeneration

To evaluate subjects with Non-foveal Geographic Atrophy Secondary to Age Related Macular Degeneration by sequencing selected genes associated with AMD. Subjects who meet eligibility criteria will have the option to participate in ongoing or future Gyroscope Therapeutic sponsored studies.


DRCR-Protocol AJ- Macula Hole

Vitreous Proteomics in Eyes with a Macular Hole.


DRCR- Protocol AM- Epiretinal Membranes

Randomized Trial Comparing Immediate versus Deferred Surgery for Symptomatic Epiretinal Membranes.

Enroll in a Study

For more information about clinical trials or if you should have any questions, please feel free to contact us.